Security key
31189P102
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 95,368,059
- Total 13F value
- $356,677,597
- Share change
- -3,121,583
- Put/Call ratio
- 41%
- SEC-reported price per share
- $3.74
- Number of holders
- 152
- Value change
- -$5,241,221
- Number of buys
- 59
- Number of sells
- 95
- Shares outstanding
- 115,488,632
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
152
Top holders
10
FATE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Previous quarter: Q3 2023
FATE THERAPEUTICS INC SEC filings
FATE THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31189P102
Recent filing periods:
Ownership snapshot
Top reported holders of FATE - FATE THERAPEUTICS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Redmile Group, LLC
Disclosed value leader
Redmile Group, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
Redmile Group, LLC leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Redmile Group, LLC's linked filing trail.
Comparable ownership
Top 5
Redmile Group, LLC
11%
BlackRock Finance, Inc.
11%
VANGUARD GROUP INC
9.4%
Bellevue Group AG
4.2%
D. E. Shaw & Co., Inc.
4.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
Company
|
11%
|
$27,823,785
13,124,427 shares
|
— | 30 Sep 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
11%
|
$26,467,121
12,484,490 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
9.4%
|
$23,125,704
10,908,351 shares
|
— | 30 Sep 2023 |
| Bellevue Group AG |
13F
Company
|
4.2%
|
$10,285,347
4,851,579 shares
|
— | 30 Sep 2023 |
| D. E. Shaw & Co., Inc. |
13F
Company
|
4.1%
|
$9,988,728
4,711,664 shares
|
— | 30 Sep 2023 |
| JOHNSON & JOHNSON |
13F
Company
|
2.9%
|
$7,163,616
3,379,064 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
152
Shares
95,368,059
Rows available
152
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
164
Q4 2023 holders
152
Holder diff
-12
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend